14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $260.68 $288.54 Thursday, 25th Apr 2024 AMGN stock ended at $269.38. This is 1.33% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 2.66% from a day low at $267.24 to a day high of $274.35.
90 days $260.68 $329.72
52 weeks $211.73 $329.72

Historical Amgen Inc. prices

Date Open High Low Close Volume
Apr 25, 2024 $273.45 $274.35 $267.24 $269.38 1 759 651
Apr 24, 2024 $270.63 $274.86 $269.65 $273.01 2 457 996
Apr 23, 2024 $272.14 $274.48 $271.05 $273.54 2 492 536
Apr 22, 2024 $270.00 $273.14 $269.84 $271.91 2 139 134
Apr 19, 2024 $264.63 $269.38 $260.68 $268.93 3 373 751
Apr 18, 2024 $265.64 $265.92 $262.58 $262.75 1 983 963
Apr 17, 2024 $267.54 $268.78 $263.39 $264.07 2 167 857
Apr 16, 2024 $266.83 $266.83 $263.81 $265.64 2 011 145
Apr 15, 2024 $269.93 $270.93 $264.35 $265.51 1 731 398
Apr 12, 2024 $268.77 $269.30 $266.17 $267.28 2 092 550
Apr 11, 2024 $270.22 $273.00 $268.45 $270.00 2 151 371
Apr 10, 2024 $267.96 $268.38 $264.63 $266.45 1 939 097
Apr 09, 2024 $270.19 $271.29 $268.58 $270.36 1 788 057
Apr 08, 2024 $269.48 $270.11 $267.56 $269.20 1 830 090
Apr 05, 2024 $265.90 $273.07 $265.12 $269.95 2 288 079
Apr 04, 2024 $276.05 $276.73 $267.75 $268.09 2 448 734
Apr 03, 2024 $275.69 $276.47 $273.68 $274.42 1 667 318
Apr 02, 2024 $283.34 $283.91 $276.04 $276.21 2 218 545
Apr 01, 2024 $282.11 $283.83 $279.00 $283.04 1 780 936
Mar 28, 2024 $287.84 $288.54 $284.21 $284.32 2 284 853
Mar 27, 2024 $284.22 $286.82 $282.55 $286.30 2 255 448
Mar 26, 2024 $282.15 $284.50 $280.70 $281.77 3 336 794
Mar 25, 2024 $276.43 $281.33 $275.41 $280.82 2 931 207
Mar 22, 2024 $277.39 $278.27 $275.10 $276.17 2 300 882
Mar 21, 2024 $274.63 $277.92 $274.61 $276.95 2 488 325
Click to get the best stock tips daily for free!

About Amgen Inc.

Amgen. Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopaus... AMGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT